Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2013

Oct 22, 2013

35380_dirs_2013-10-22_1de46d8f-56e9-4f1c-bfcd-078eee02ac96.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2013-10-18

Reporting Person: Sullivan Michael O'Keefe (CFO, Secretary and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-10-18 Common Stock A 54304 Acquired 111543 Direct
2013-10-18 Common Stock F 19000 $2.99 Disposed 92543 Direct

Footnotes

F1: Represents a performance award of 54,304 shares made in connection with, and as part of, the previously approved long-term compensation program adopted by the Company and made pursuant to an award agreement with the reporting individual. The award was made under the Company's 2012 Equity Incentive Plan (the "Plan") and was based upon the determination that a specified performance goal related to the Company's entering into a new collaboration agreement had been achieved. The award determination was made on October 18, 2013, and closing price of the Company's stock on such date was $2.99.

F2: Represents withholding of shares of common stock to satisfy tax withholding obligations in connection with the issuance of the performance share award.